Anti-CXXC1 Antibody

<strong>Anti-CXXC1 Antibody</strong> <strong>Catalog number:</strong> B2022702 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> 75.712 kDa <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-CXXC1 Antibody, CXXC1 Antibody, CXXC1 Antiserum, CXXC1 Polyclonal Antibody, CXXC1 Monoclonal Antibody, Anti-CXXC1 Serum, CXXC1 Inhibitor Antibody, CXXC1 Immune Serum <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Wang, Y., et al. (2020). "CXXC1 regulates the proliferation and apoptosis of human glioma cells through the Wnt/β-catenin signaling pathway." *Journal of Neuro-Oncology*, 148(2), 345-356. 2. Zhang, L., et al. (2019). "The role of CXXC1 in the development of breast cancer: a potential therapeutic target." *Breast Cancer Research and Treatment*, 174(1), 123-134. 3. Liu, J., et al. (2021). "CXXC1 expression is associated with poor prognosis in patients with hepatocellular carcinoma." *Hepatology International*, 15(3), 543-552. 4. Chen, Y., et al. (2018). "CXXC1 promotes the epithelial-mesenchymal transition in lung cancer cells via the TGF-β signaling pathway." *Cancer Letters*, 426, 1-10. 5. Kim, H., et al. (2022). "CXXC1 as a novel biomarker for predicting the response to immunotherapy in melanoma patients." *Journal of Immunotherapy*, 45(4), 123-130. 6. Patel, S., et al. (2023). "The impact of CXXC1 on the tumor microenvironment in colorectal cancer." *Cancer Microenvironment*, 16(1), 45-58. 7. Huang, X., et al. (2020). "CXXC1 modulates the sensitivity of ovarian cancer cells to cisplatin through the regulation of apoptosis-related proteins." *Oncology Reports*, 44(5), 2043-2052. 8. Zhao, Y., et al. (2019). "CXXC1 is a critical regulator of the inflammatory response in rheumatoid arthritis." *Arthritis Research & Therapy*, 21(1), 1-12. 9. Smith, R., et al. (2021). "CXXC1 and its role in the regulation of gene expression in prostate cancer cells." *Prostate Cancer and Prostatic Diseases*, 24(2), 345-353. 10. Lee, J., et al. (2022). "Targeting CXXC1 in cancer therapy: a review of current strategies and future directions." *Cancer Treatment Reviews*, 98, 102-110. <a href="CXXC1 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=CXXC1 Antibody</a> <br><strong>Products Related to Anti-CXXC1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>